Duke-NUS highlights potential role of bioaerosol sampling to address airborne biological threats

Singapore – As a leading global city with a high population density, Singapore is vulnerable to the introduction o...

December 11, 2018 | Tuesday | News
Tychan begins Phase I Trials for first ever yellow fever drug

Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate dru...

December 7, 2018 | Friday | News
PAREXEL, Eli Lilly to develop China’s Clinical Research workforce

PAREXEL, a leading innovator of global biopharmaceutical services, has announced a new collaboration with Eli Lilly and ...

December 6, 2018 | Thursday | News
argenx collaborates with Cilag GmbH International

argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...

December 3, 2018 | Monday | News
ViaCyte Secures $80 Million Financing for Insulin-Requiring Diabetes

Clinical stage regenerative medicine company has announced an $80 million Series D financing led by Bain Capital Life Sc...

November 30, 2018 | Friday | News
Tessa appoints Dr. Ivan Horak as president of R&D

Singapore –Tessa Therapeutics, a clinical stage biopharmaceutical company focusing on cellular immunotherapy ...

November 29, 2018 | Thursday | News
DRC initiates first-ever multi-drug Ebola trial

First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republ...

November 27, 2018 | Tuesday | News
First asian real-world experience of regorafenib presented at ESMO Asia

Singapore – A new multicenter, retrospective analysis of South Korean patients highlighted that the oral targeted ...

November 26, 2018 | Monday | News
Merck, Pfizer give information of Avelumab in Refractory Ovarian Cancer

Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combinatio...

November 20, 2018 | Tuesday | News
Vyera to Initiate Phase 1 Study of NCE for Toxoplasmosis

Vyera Pharmaceuticals, LLC  has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of ...

November 16, 2018 | Friday | News
Nashville Biosciences enters into agreement with BC Platforms

Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...

November 15, 2018 | Thursday | News
3-D study delivers first pre-clinical results on the toxicological impact of novel e-cigarette

Singapore - Philip Morris International (PMI), has conducted an in vitro study using epithelial cells taken from the mou...

November 12, 2018 | Monday | News
Adagene announces acceptance of IND in China for ADG-106

Adagene, an innovative antibody engineering and discovery company based in Suzhou, China as well as San Francisco, Calif...

November 1, 2018 | Thursday | News
Daiichi enters clinical collaboration with Merck, Pfizer

Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck K...

October 27, 2018 | Saturday | News
Eisai announces Data from the Phase II Clinical Trial of BAN2401

Eisai Co., Ltd. and Biogen Inc. announced that Eisai presented the latest data from the Phase II clinical study (Study 2...

October 26, 2018 | Friday | News
Reistone Biopharma to intiate Ph 2 clinical trial of Ulcerative Colitis globally

Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced&...

October 23, 2018 | Tuesday | News
ASLAN reveals promising data for advanced solid tumour drug

Singapore – ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both...

October 22, 2018 | Monday | News
apceth Biopharma announces positive results for apceth-201 in mouse models

apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies...

October 19, 2018 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls